Piepsz A, Tondeur M, Kinthaert J, Ham H R
Department of Radioisotopes, Hôpital Saint-Pierre, 322, Rue Haute, B-1000 Brussels, Belgium.
Eur J Nucl Med. 1996 Feb;23(2):195-8. doi: 10.1007/BF01731844.
The aim of this paper was to determine the reproducibility (precision) of technetium-99m mercaptoacetyltriglycine (MAG3) clearance and to compare it with that of chromium-51 ethylenediamine tetra-acetic acid (EDTA). Twelve young volunteers (aged between 21 and 34 years), without any history of medical problems, were enrolled in this study. The test was performed twice, at an interval of 8 days and under similar physiological conditions. After the intravenous injection of both tracers, 15 blood samples were taken between 3 and 240 min. A biexponential fit was adapted to the plasma disappearance curves (5- to 120-min samples for 99mTc-MAG3 and 10- to 240-min samples for 51Cr-EDTA); the clearances were calculated according to Sapirstein and corrected for body surface area. The mean clearance values were 110 (range 85-130) and 226 (range 109-319)ml/min/1.73 m2, respectively, for 51Cr-EDTA and 99mTc-MAG3. For 51Cr-EDTA clearance, the mean difference between the first and the second measurement was -2.1% of the mean of the two successive values (SD: 8.4%). In ten cases, the difference was less than 12%; in two cases, the differences were 15% and 18%, respectively. For 99mTc-MAG3 clearance, the mean difference between the first and the second measurement was -20% of the mean of the two successive values (SD: 25%). In six cases, the difference was less than 12%; in four cases, between 15% and 40%; and in two cases, more than 60%. Methodological factors (impurities contained in the commercial kit, variable protein binding) as well as physiological factors (pH of urine, sodium load, stress) may explain the lack of precision of the 99mTc-MAG3 clearance. It is concluded that changes in 99mTc-MAG3 plasma clearance should be interpreted with care in daily routine.
本文旨在确定锝-99m 巯基乙酰三甘氨酸(MAG3)清除率的可重复性(精密度),并将其与铬-51 乙二胺四乙酸(EDTA)的可重复性进行比较。12 名无任何病史的年轻志愿者(年龄在 21 至 34 岁之间)参与了本研究。在间隔 8 天且生理条件相似的情况下进行了两次测试。静脉注射两种示踪剂后,在 3 至 240 分钟内采集了 15 份血样。对血浆消失曲线采用双指数拟合(99mTc-MAG3 为 5 至 120 分钟的样本,51Cr-EDTA 为 10 至 240 分钟的样本);清除率根据萨皮尔斯坦法计算,并校正体表面积。51Cr-EDTA 和 99mTc-MAG3 的平均清除率值分别为 110(范围 85 - 130)和 226(范围 109 - 319)ml/min/1.73 m²。对于 51Cr-EDTA 清除率,第一次和第二次测量的平均差值为连续两次测量平均值的 -2.1%(标准差:8.4%)。在 10 例中,差值小于 12%;在 2 例中,差值分别为 15%和 18%。对于 99mTc-MAG3 清除率,第一次和第二次测量的平均差值为连续两次测量平均值的 -20%(标准差:25%)。在 6 例中,差值小于 12%;在 4 例中,差值在 15%至 40%之间;在 2 例中,差值超过 60%。方法学因素(商业试剂盒中含有的杂质、可变的蛋白质结合)以及生理因素(尿液 pH 值、钠负荷、应激)可能解释了 99mTc-MAG3 清除率缺乏精密度的原因。得出的结论是,在日常临床中对 99mTc-MAG3 血浆清除率的变化应谨慎解读。